US Patent Issued to SINOPEP-ALLSINO BIOPHARMACEUTICAL, HANGZHOU SINOPEP-ALLSINO PHARMACEUTICAL TECHNOLOGY DEVELOPMENT on March 31 for "GLP-1 agonist polypeptide compound and salt thereof, synthesis method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,134, issued on March 31, was assigned to SINOPEP-ALLSINO BIOPHARMACEUTICAL Co. LTD. (Lianyungang, China) and HANGZHOU SINOPEP-ALLSINO PHARMACEUTICAL TECHNOLOGY DEVELOPMENT Co. LTD. (Hangzhou, China).

"GLP-1 agonist polypeptide compound and salt thereof, synthesis method therefor and use thereof" was invented by Chengqing Zhao (Lianyungang, China), Guoqiang Shi (Lianyungang, China), Shunzi Li (Lianyungang, China) and Caidian Wang (Lianyungang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides a GLP-1 agonist polypeptide compound having an amino acid sequence: H Xaa1EGTFTSDVSSYLE Xaa2QAA Xaa3EFIAWLVRGRG (SEQ ID NO: 1). The ...